-
A prospective randomized, placebo-controlled, multi-center trial demonstrates that a prolonged course of intravenous selenium improves mortality in patients with severe sepsis and septic shock and is associated with minimal to no side effects.
-
The incidence of invasive infections due to MRSA in 2005 was approximately 100 times greater in chronic dialysis patients than in the general population.
-
Since the publication of the initial IDSA Guidelines for the Management of Community-Acquired Pneumonia in 2003, hospital administrators have been scrambling to improve their numbers.
-
Unfractionated heparin (UH) is commonly used in acutely ill hospital patients at risk for venous thromboembolism (VTE).
-
Among 413 patients who underwent placement of a removable inferior vena cava filter following trauma for prophylaxis or treatment of pulmonary thromboembolism and survived to hospital discharge, subsequent removal of the filter was attempted in 116 of them and successful in only 91 (22%).
-
IVIG is safe and effective for worsening Myasthenia Gravis, but has no effect on the natural course of Miller Fisher syndrome.
-
Compared with a lower dose, intensive treatment with atorvastatin in patients with stable coronary disease significantly reduces hospitalizations for HF.
-
Obesity and the magnitude of nocturnal oxygen desaturation, which is an important pathophysiological consequence of OSA, are independent risk factors for incident AF in individuals <65 years of age.
-
Elimination of daily routine CXRs reduced the number of CXRs in a mixed medical-surgical ICU, while not affecting readmission rate and ICU and hospital mortality rates.
-
Current AP schedules do not appear to prevent catheter-related thrombosis. Systemic VTE and mortality, however, appeared lower after prophylaxis.
